LayerBio's OcuRing-K ketorolac devise has potential to disrupt NSAID delivery in cataract surgery

Featured Posts

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen attends ACS Fall 2018 National Meeting!

CreaGen attends ACS Fall 2018 National Meeting!

C2I hosts exciting private summer social!

C2I hosts exciting private summer social!

CreaGen Life Science Incubator (C2I) is expanding!

CreaGen Life Science Incubator (C2I) is expanding!

6th Annual Advances in Chemical Sciences Symposium

6th Annual Advances in Chemical Sciences Symposium

Recent Posts

Congratulations to our partner, Middlesex Community College, on the opening of their lab facility!

Join us for a Lunch & Learn with Dr. Neal Kalechofsky of AwardIT!

C2I Summer Mixer 2022

Welcome to C2I, Anastasis Bio Corp Drug Development LLC!

Welcome to C2I, Cellens Inc.!

Welcome to C2I, Anagenex!

ChemoMetec and C2I Accelerator Brunch & Learn

C2I Entrepreneur Forum: Start-up Space in Life Science - Figuring Out Where You Belong

Fluidic Analytics' publication is selected for the ACS Editors' Choice

Join us at C2I Webinar Entrepreneur Forum for a panel discussion on "Start-up Space in Life Science"

Follow Us